Filing Flows

Filing Flows › Caris Life Sciences (CAI) › Who owns the stock

Who owns Caris Life Sciences (CAI) stock

237 funds reported Caris Life Sciences (CAI) shares in their latest 13F filings, worth $2.4B in all. The largest holder is FMR LLC ($551M). Last quarter 150 funds added to their stakes and 63 cut them.

Largest holders of CAI (13F)Largest holders of CAI (13F)FMR LLC$551MJ. H. Whitney Equity Partners VI,…$201MCoatue Management LLC$175MPointState Capital LP$122MBlackRock$98.7MT. Rowe Price Investment Manageme…$90.5MVanguard Portfolio Management LLC$86.3MVanguard Capital Management LLC$76.3MAmundi$71.8MNeuberger Berman Group LLC$64.0M

Largest holders (13F)

FundSharesValueChangeQuarter
FMR LLC30,923,878$551Mincrease2026-06-30
J. H. Whitney Equity Partners VI, LLC11,256,615$201Mdecrease2026-06-30
Coatue Management LLC9,819,992$175Munchanged2026-06-30
PointState Capital LP6,828,835$122Mdecrease2026-06-30
BlackRock5,536,798$98.7Mincrease2026-06-30
T. Rowe Price Investment Management5,079,141$90.5Mdecrease2026-06-30
Vanguard Portfolio Management LLC4,844,431$86.3Mincrease2026-06-30
Vanguard Capital Management LLC4,280,238$76.3Mincrease2026-06-30
Amundi2,344,238$71.8Mincrease2026-09-30
Neuberger Berman Group LLC3,590,963$64.0Mincrease2026-06-30
Orbimed Advisors LLC2,806,811$50.0Munchanged2026-06-30
BNP Paribas Financial Markets2,370,268$42.2Mincrease2026-06-30
Millennium Management LLC2,202,647$39.3Mincrease2026-06-30
Deutsche Bank Ag\1,279,032$39.2Mincrease2026-09-30
MAK Capital One LLC1,937,229$34.5Mnew2026-06-30

Caris Life Sciences' latest quarter

Caris Life Sciences, Q3 2026: revenue $275M (+27% year over year), operating margin 7.0%, net earnings $15.2M, operating cash flow −$22.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CAI stock?

By the latest 13F filings: FMR LLC ($551M); J. H. Whitney Equity Partners VI, LLC ($201M); Coatue Management LLC ($175M); PointState Capital LP ($122M); BlackRock ($98.7M).

What is the short interest in CAI?

13,589,186 shares were sold short at the 2026-10-15 settlement, -2.18% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.